Decoding the
Human Signal
We combine high-fidelity biosensors with proprietary AI models to predict cardiovascular events before they happen.
Initialize PartnershipThe Silent Failure
Cardiovascular disease is a data problem. Current diagnostics miss the subtle, early-warning patterns in endothelial function and heart rate variability.
From Signal to Risk Score
We start with the signals today's devices capture — and systematically add the markers that predict cardiovascular events years before they occur.
Foundation Metrics
- Heart Rate & HRV
- SpO2 / Oxygen Saturation
- ECG & PPG Signal
- Respiration Rate
- Motion-corrected ambulatory ECG
Advanced Vascular Markers
- Flow-Mediated Dilation (FMD)
- Endothelial Function Index
- Blood Pressure Trending
- Arterial Stiffness Proxy
Holistic Risk Intelligence
- Unified cardiovascular risk score
- Longitudinal trend analysis
- Clinician-ready risk reports
The Neural Engine
Our proprietary stack processes raw sensor data at the edge, extracting clinical features in real-time.
1. Ingestion
High-frequency sampling of PPG & ECG raw data inputs
2. Feature Extraction
Advanced signal processing and AI/CNNs
3. Prediction
Risk scoring against our proprietary clinical dataset
The Aoknos Platform
Flow-Mediated Dilation
Non-invasive assessment of endothelial function. We capture vascular reactivity data that standard cuffs miss.
AI-Denoising
Proprietary algorithms filter motion artifacts from ambulatory ECGs, delivering clinical-grade fidelity in motion.
Predictive Vitals
Real-time streaming of HRV, Oxygen Saturation, and Blood Pressure trends directly to the cloud.
Beyond the Consumer Wearable
Standard wearables count steps. Clinical monitors require clinic visits. Neither was built to catch cardiovascular disease early — we were.
Heart rate and SpO2, nothing more
Consumer wearables capture surface-level metrics. They cannot measure vascular reactivity or endothelial function — the earliest known indicators of cardiovascular risk.
Motion makes signals unusable
Ambulatory ECG degrades the moment a patient moves. Most wearable ECGs are only reliable at rest, limiting their clinical value to static snapshots.
Isolated alerts, no context
Each metric is evaluated independently. A single high reading triggers an alarm — but no device synthesizes the full picture into an actionable risk assessment.
Gold-standard tests stay in the clinic
Flow-Mediated Dilation requires specialist equipment, a trained technician, and a hospital visit. It is never available continuously or at the point of care.
FMD and beyond — on a single device
We are the first platform to bring Flow-Mediated Dilation into an ambulatory form factor, alongside a full suite of cardiovascular biosignals captured continuously.
Clinical-grade signal in motion
Our proprietary AI denoising removes motion artifacts in real time, delivering clean, clinically interpretable ECG data whether the patient is resting, walking, or exercising.
One unified risk score
Our ML engine synthesizes every captured signal — HRV, SpO2, FMD, ECG morphology — into a single, longitudinal cardiovascular risk score that evolves with the patient.
Continuous, anywhere monitoring
Edge-processed on the device. No clinic visit required. Clinicians receive structured risk reports continuously, enabling intervention before symptoms appear.
